Literature DB >> 24970930

Defective anti-polysaccharide response and splenic marginal zone disorganization in ALPS patients.

Bénédicte Neven1, Julie Bruneau2, Marie-Claude Stolzenberg3, Isabelle Meyts4, Aude Magerus-Chatinet3, Leen Moens5, Nina Lanzarotti3, Sandra Weller6, Denise Amiranoff7, Benoit Florkin8, Brigitte Bader-Meunier1, Guy Leverger9, Alice Ferster10, Christophe Chantrain11, Stéphane Blanche12, Capucine Picard13, Thierry Jo Molina14, Nicole Brousse14, Anne Durandy3, Marta Rizzi15, Xavier Bossuyt6, Alain Fischer16, Frederic Rieux-Laucat3.   

Abstract

Autoimmune lymphoproliferative syndrome (ALPS) caused by impaired FAS-mediated apoptosis of lymphocytes is characterized by lymphoproliferation, autoimmunity, but also an increased risk of invasive bacterial infection, notably following splenectomy. We surveyed a cohort of 100 ALPS patients (including 33 splenectomized) and found that 12 (10 splenectomized) had experienced 23 invasive bacterial infections mainly caused by Streptococcus pneumoniae. This vulnerability was associated with evidence of defective B-cell function characterized by low serum immunoglobulin (Ig) M, low IgM antibody production in response to S pneumoniae following nonconjugated immunization, and low blood memory B-cells counts (including marginal zone [MZ] B-cell counts). This immunodeficiency strongly correlated with intensity of lymphoproliferation. Spleen sections from 9 ALPS patients revealed double-negative T-cell (DN-T) infiltration of the MZ, which was depleted of B cells. MZ in ALPS patients contained an abnormally thick layer of MAdCAM-1((+)) stromal cells and an excess of DN-Ts. DN-Ts were shown to express MAdCAM-1 ligand, the α4β7 integrin. These observations suggest that accumulating DN-Ts are trapped within stromal cell meshwork and interfere with correct localization of MZ B cells. Similar observations were made in spleens of fas-deficient mice. Our data revealed an unexpected mechanism by which ALPS results in anti-polysaccharide IgM antibody production-specific defect. Splenectomy should be avoided.
© 2014 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24970930     DOI: 10.1182/blood-2014-02-553834

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  15 in total

Review 1.  Updated Understanding of Autoimmune Lymphoproliferative Syndrome (ALPS).

Authors:  Pu Li; Ping Huang; Ye Yang; Mu Hao; Hongwei Peng; Fei Li
Journal:  Clin Rev Allergy Immunol       Date:  2016-02       Impact factor: 8.667

2.  Marginal zone B-cell dysfunction in ALPS.

Authors:  Joao Bosco Oliveira
Journal:  Blood       Date:  2014-09-04       Impact factor: 22.113

3.  Autoimmune Lymphoproliferative Syndrome Presenting with Invasive Streptococcus pneumoniae Infection.

Authors:  Eric Oksenhendler; András N Spaan; Bénédicte Neven; Marie-Claude Stolzenberg; Mathieu Fusaro; Jean-Laurent Casanova; Frédéric Rieux-Laucat; Bertrand Boisson; Aude Magérus
Journal:  J Clin Immunol       Date:  2020-03-06       Impact factor: 8.317

Review 4.  Turf wars: exploring splenomegaly in sickle cell disease in malaria-endemic regions.

Authors:  Venée N Tubman; Julie Makani
Journal:  Br J Haematol       Date:  2017-05-11       Impact factor: 6.998

Review 5.  The Autoimmune Lymphoproliferative Syndrome with Defective FAS or FAS-Ligand Functions.

Authors:  Frédéric Rieux-Laucat; Aude Magérus-Chatinet; Bénédicte Neven
Journal:  J Clin Immunol       Date:  2018-06-17       Impact factor: 8.317

6.  Long-term remission rates after splenectomy in adults with Evans syndrome compared to immune thrombocytopenia: A single-center retrospective study.

Authors:  Emilio D Sulpizio; Vikram Raghunathan; Joseph J Shatzel; Jevgenia Zilberman-Rudenko; Tarin Worrest; Brett C Sheppard; Thomas G DeLoughery
Journal:  Eur J Haematol       Date:  2019-10-27       Impact factor: 2.997

Review 7.  Warm antibody autoimmune hemolytic anemia.

Authors:  Theodosia A Kalfa
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

8.  Pulmonary Manifestations of the Autoimmune Lymphoproliferative Syndrome. A Retrospective Study of a Unique Patient Cohort.

Authors:  Chuen-Yen Lau; Andrew D Mihalek; Jing Wang; Lori E Dodd; Katie Perkins; Susan Price; Sharon Webster; Stefania Pittaluga; Les R Folio; V Koneti Rao; Kenneth N Olivier
Journal:  Ann Am Thorac Soc       Date:  2016-08

Review 9.  Splenomegaly in Children and Adolescents.

Authors:  Meinolf Suttorp; Carl Friedrich Classen
Journal:  Front Pediatr       Date:  2021-07-09       Impact factor: 3.418

Review 10.  Approaches to Managing Autoimmune Cytopenias in Novel Immunological Disorders with Genetic Underpinnings Like Autoimmune Lymphoproliferative Syndrome.

Authors:  V Koneti Rao
Journal:  Front Pediatr       Date:  2015-07-21       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.